Physician profile
John J Bardash
NPI 1699951004
$2,802.12
in general payments reported to CMS, 2019-2025
17 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $290 · 2021: $557 · 2022: $641 · 2023: $260 · 2024: $300 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $837.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $836.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $631.02 | 2019-2024 | Clariti Contact Lens, Biofinity Contact Lens |
| Johnson & Johnson Vision Care, INC. | $615.49 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $583.21 | 2022-2025 | Infuse, Infuse Multifocal, Miebo |
| Alcon Vision LLC | $197.29 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $155.67 | 2024 | Xdemvy |
| Abbvie INC. | $135.86 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $98.80 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $93.62 | 2021-2025 | Lipiflow System Activator (Disposable) |
| Mallinckrodt Hospital Products INC. | $81.55 | 2022-2025 | Acthar |
| Optos, INC. | $46.81 | 2019 | |
| Thea Pharma INC. | $40.83 | 2022 | |
| Lombart Brothers, INC. | $36.82 | 2021-2022 | |
| Harrow Eye, LLC | $22.45 | 2025 | Vevye |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Oyster Point Pharma, INC. | $18.18 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abb Con-Cise Optical Group LLC | $12.63 | 2019 | |
| Allergan, INC. | $12.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bardash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.